In concordance, factor inclusion probability analysis using the Bayesian linear regression model showed that, while SRD5A1 (ENSG00000145545.10), SHBG (ENSG00000129214.13), HSD17B3 (ENSG00000130948.8), and HSD17B2 (ENSG00000086696.9) transcended the threshold for inclusion as predictors of recurrence or “new tumor event after initial treatment”, PSA value and age at diagnosis did not (Figure 6A). The gene discussed is HSD17B3; the disease is neoplasm.